Cyclodextrin treatment leads to atherosclerosis regression by dissolution of cholesterol crystals and LXR activation
Ontology highlight
ABSTRACT: Atherosclerosis is an inflammatory disease linked to elevated blood cholesterol levels. Since cholesterol retention and cholesterol crystals in arterial walls are key pathogenetic factors for atherogenesis, we assessed the therapeutic potential of increasing cholesterol solubility in vivo. Here we show that treatment of murine atherosclerosis with the cyclic oligosaccharide 2-hydroxypropyl-β-cyclodextrin (CD), a compound that solubilizes lipophilic substances, reduced atherosclerotic plaque size, cholesterol crystal (CC) load and promoted plaque regression even under continuing Western diet. CD solubilized CC and promoted cholesterylester and oxysterol production in macrophages leading to liver X receptor-mediated transcriptional reprogramming with increased cholesterol efflux and decreased inflammation. CD treatment may thus be used to increase cholesterol solubility and clearance to prevent or treat atherosclerosis.
ORGANISM(S): Mus musculus
PROVIDER: GSE47696 | GEO | 2017/07/01
SECONDARY ACCESSION(S): PRJNA207331
REPOSITORIES: GEO
ACCESS DATA